Are you Dr. Dinney?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 42 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Summary
- Dr. Colin Dinney, MD is a urologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Florida, and Oklahoma. He is affiliated with University of Texas M.D. Anderson Cancer Center and is a Professor at Division of Surgery.
Education & Training
University of ManitobaClass of 1982
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 1991 - 2026
OK State Medical License 2020 - 2021
Awards, Honors, & Recognition
- Top Doctors:SE Texas Castle Connolly, 2013
- Super Doctor SuperDoctors.com
Clinical Trials
- AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer Start of enrollment: 1998 Nov 01
- Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium Start of enrollment: 2001 Jul 01
- Screening for Bladder Cancer Start of enrollment: 2007 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis.Sangkyou Lee, Jolanta Bondaruk, Yishan Wang, Huiqin Chen, June Goo Lee, Tadeusz Majewski, Rachel D Mullen, David Cogdell, Jiansong Chen, Ziqiao Wang, Hui Yao, Pawel Ku...> ;Cell Reports. 2024 Apr 25
- Inferring Bladder Cancer Evolution from Mucosal field Effects by Whole-Organ Spatial Mutational, Proteomic, and Metabolomic Mapping.Bogdan Czerniak, Sangkyou Lee, Sung Yun Jung, Pawel Kus, Jolanta Bondaruk, June Lee, Roman Jaksik, Nagireddy Putluri, Khanh Dinh, David Cogdell, Huiqin Chen, Yishan Wa...> ;Research Square. 2024 Apr 10
- Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy.Contieri, R., Tan, W., Hensley, P., Martini, A., Nogueras-Gonzalez, G., Grajales, V., Bree, K., Myers, A., Navai, N., Dinney, C., Guo, C., Kamat, A.> ;BJU International. 2024 Feb 19
- Join now to see all
Press Mentions
Β-arrestins Regulate Stem Cell-like Phenotype and Response to Chemotherapy in Bladder CancerFebruary 20th, 2020
Ferring + Blackstone Life Sciences Launch New Oncology Company to Further Treatment for Invasive Bladder CancerNovember 25th, 2019
One of the World’s Largest Private Equity Firms Enters Targets Unmet Need for Bladder Cancer with Swiss PharmaNovember 25th, 2019- Join now to see all
Grant Support
- Developmental Research ProgramNational Cancer Institute2008–2010
- Career Developement ProgramNational Cancer Institute2008–2010
- Administrative CoreNational Cancer Institute2008–2010
- Spore In Genitourinary CancerNational Cancer Institute2006–2010
- M. D. Anderson Cancer Spore In Genitourinary CancersNational Cancer Institute2001–2005
- Biology Of Bladder Cancer MetastasesNational Cancer Institute1996–2000
Professional Memberships
- Member
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
